Gilead (GILD) CFO Andrew D. Dickinson Sells 3,000 Shares

What Happened
Andrew D. Dickinson, Chief Financial Officer of Gilead Sciences, sold 3,000 shares on August 17, 2026 at $138.36 per share, generating proceeds of $415,080. The filing lists the transaction as a sale (S) executed via an open-market or private sale.

Key Details

• Transaction date and price: August 17, 2026 — 3,000 shares at $138.36 each.
• Total value: $415,080 (proceeds from the sale).
• Shares owned after transaction: Not specified in the details provided.
• Footnote: The sale was made pursuant to a Rule 10b5-1 trading plan adopted August 29, 2024.
• Filing timing: Reported on Aug 18, 2026 for an Aug 17 transaction (appears to be timely).

Context
Sales by executives are often routine (e.g., diversification, preplanned trading). The presence of a 10b5-1 plan indicates this sale was part of a pre-established arrangement and not necessarily a reaction to inside information. For retail investors, purchases typically signal stronger insider conviction than routine sales; this filing documents a scheduled disposal of shares.